A federal jury in Dallas has delivered a resounding verdict, convicting Texas laboratory owner and former NFL player Keith J.…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
The Centers for Medicare and Medicaid Services (CMS) has initiated a critical dialogue with the clinical laboratory community, seeking direct…
Read More
Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.
A federal jury in Dallas has delivered a decisive verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…
Read More
CMS Launches Sweeping Anti-Fraud Initiative, Targeting Genetic Testing Spending and Soliciting Lab Industry Input for Future Regulations
The Centers for Medicare and Medicaid Services (CMS) has embarked on a significant preemptive strike against healthcare fraud, initiating a…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
Clinical laboratory leaders faced a critical, albeit narrowing, window to influence a significant new federal anti-fraud initiative launched by the…
Read More
